Ethan Zohn details his cancer battle to Yahoo Life. (Photo: Ethan Zohn)
Ethan Zohn is a survivor in more ways than one. The former professional soccer player rose to fame after taking home the ultimate prize on Survivor: Africa in 2001, going on to compete on the long-running reality show twice more, as well as on programs like The Amazing Race and Fear Factor. It was in 2009, however, that he faced his most personal challenge yet: a lymphoma diagnosis.
Now, Zohn who used some of his Survivor prize money to co-found Grassroot Soccer, an organization in support of HIV-AIDS prevention in Africa is an ambassador for the Lymphoma Research Foundation, the nations largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community with education programs, outreach initiatives and support services. Thus far, LRF has raised more than $67 million for the cause, which is close to Zohns heart he credits lymphoma research with saving his life following the failure of several cancer treatments.
The reality star, who returned to Survivor last year for its 20th anniversary Winners at War season, spoke to Yahoo Life about what hes learned from beating cancer and how Survivor changed the trajectory of his life.
What would you tell yourself looking back on your reality TV experience?
I would probably tell myself, "Dude, dont take everything so seriously." The whole reason I tried out for Survivor was because of a series of epic failures in my life. I was cut from my soccer team, I was unemployed, I got an advertising job in New York I was fired from. I told my mom, "Everything is okay, Ill get a job, Im just between life choices." I signed up for Survivor on a whim, and I got on. Back then, I was just a dude looking for an adventure, so when Survivor ended it was so crazy I was in the public eye, giving speeches and appearances, and it just got so overwhelming. I thought everything meant so much. Every single thing I said in a magazine. But fast forward a bunch of years, and cancer hit, and all that little stuff means nothing in the grand scheme of things. With cancer, things got pretty clear pretty quickly, so I wish I didnt spend so much time stressing out about every little thing how my hair looked. Stuff like that.
Ethan Zohn, a three-time Survivor contestant, details his cancer battle to Yahoo Life. (Photo: Ethan Zohn)
What was your cancer diagnosis experience?
In 2008, I was working with Grassroot Soccer, which is the charity that I started using the money from Survivor to start. I did this big campaign where I dribbled a soccer ball from Boston to Washington, D.C. I started getting really itchy skin, and I tried every pill, cream and lotion known to man but it didnt help. Eventually, I was diagnosed with CD20-positive Hodgkin's lymphoma. The shock of getting that diagnosis was magnified as the only connection I had to cancer was through my dad. When I was 14, cancer came and took my dad away from me. Cancer, to me, equaled death, so when I was diagnosed, I was petrified. I was 35, I was training for the New York City Marathon. I was a healthy, young guy. You never expect it to be you. When all my friends were starting their life, I had to press pause on mine.
I went through multiple rounds of chemotherapy, 22 blasts of radiation, stem cell therapy, which worked for a little while but 20 months later the cancer returned. Getting the news that the cancer had returned was deflating, because I had already had treatment and I was running out of options. Fortunately, at that exact moment in time, just when I needed it most, there was a new targeted therapy. I was then able to then get another stem cell treatment, using my brother as a donor.
Now, Im heavily involved with the Lymphoma Research Foundation. They do an incredible amount of work for cancer research, especially blood cancer research. Personally, I wouldnt be alive if it werent for cancer research, and for organizations like the LRF. I often think to myself, How cool is it that there are complete strangers running marathons, selling cookies, donating money for a drug that helped save my life? Thats inspiring, and one of my roles as an ambassador is to show how incredible this organization is.
What is something that you wish more people knew about cancer?
Every 10 minutes, someone is diagnosed with lymphoma in the United States. To me, thats not okay, and it is a disease that affects young adults. If youre a young adult living in the United States and youre diagnosed with cancer, most likely it is going to be lymphoma. Whats been really interesting since I returned to Survivor is that Ive connected with fans over social media. Since Im so accessible now, Ive gotten many emails and DMs from fans who are like, "I saw your symptoms and because of that I went to the doctor and got diagnosed." Its been worthwhile to share my story, to work with LRF, and to help amplify that story.
Ethan Zohn is sharing details of being a lymphoma survivor. (Photo: Ethan Zohn)
What was your most meaningful reality TV experience?
Ive been on a lot of reality shows, some Im proud of and some Im not. You can guess from IMDb which ones those are. [Laughs] But on Survivor: Africa, I won a reward challenge where I received two goats. I had to take these little goats to an African village, and before I went into town I was hanging out with these kids in the parking lot of a hospital. They were touching my skin, my hair they had never seen someone who looked like me before. I took out my luxury item, a hacky sack, and we started playing. We were having an incredible time playing and laughing speaking the same language through the game of soccer. Before I left, I asked a nurse why all the kids were hanging out by the hospital? And she said, "These are the kids who are HIV positive."
Here I was, in the middle of this cutthroat game of Survivor, and I had that real-life experience. It was the first time I saw how this disease was really affecting the community. Thats when I decided to start a charity to help kids. Now, Grassroot Soccer is in 60 countries and weve graduated 13 million kids from the program all from a silly little reality show! People often look at reality TV a certain way, but if I didnt win Survivor and that money, in that moment in the center of the AIDS pandemic, who knows what would have happened.
Who would you love to compete with in your ideal game of Survivor?
I wouldnt necessarily want to compete with these people, but Id like to hang out with them on an island. Id like to play against [Portuguese soccer player] Cristiano Ronaldo. Id like to bring my dad back and play with him. And Bob Marley, because Im a huge Bob Marley fan. Ive always wanted Survivor to do a global version of Survivor. Take the winner from each country playing Survivor, and well all play against each other. I think there are 23, 24 different countries playing Survivor.
- Stem Cell Therapy: Alternative Treatment to Hip & Knee ... - November 22nd, 2021
- How The Overlap Between Artificial Intelligence And Stem Cell Research Is Producing Exciting Results - Forbes - November 22nd, 2021
- Selma Blair Posts Nude Diving Photo After MS Stem Cell ... - November 22nd, 2021
- Stem Cell Therapy Reduces Need for Nearly 10% of Hip Replacements - Yale School of Medicine - November 22nd, 2021
- Stem cell therapy for heart failure lowers risk of adverse outcomes - Cardiovascular Business - November 22nd, 2021
- A second HIV patient may have been 'cured' of infection without stem cell treatment, in extremely rare case - CNN - November 22nd, 2021
- The Promise of Stem Cells to Help Children with Autism - Entrepreneur - November 22nd, 2021
- Global Cell Therapy Manufacturing Market Competition Forecast & Opportunities to 2026 - ResearchAndMarkets.com - Galveston County Daily News - November 22nd, 2021
- Dr Pengyi Yang wins National Stem Cell Foundation Metcalf Prize - News - The University of Sydney - November 22nd, 2021
- BioRestorative Therapies Enters into Letter of Intent with PRC Clinical - BioSpace - November 22nd, 2021
- SC21- 21st century cellular medicines specialists - The Thaiger - November 22nd, 2021
- From asthma to cancer to infertility, the new treatments, jabs and meds making us healthier... - The Sun - November 22nd, 2021
- New hope for bowel cancer patients as fresh partnership between Carina Biotech and CellVec enables advancement of clinical trials. - Bio-IT World - November 22nd, 2021
- FDA Approves Merck's KEYTRUDA (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery - Business... - November 22nd, 2021
- Mum with brain fog and pins and needles in hands devastated by 'ticking time bomb' MS - Mirror.co.uk - November 22nd, 2021
- CAR T-cell therapy: Hear from a Canadian patient - CTV News - November 8th, 2021
- Talaris therapy ends need for immune drugs in transplant patients - - pharmaphorum - November 8th, 2021
- Treatment Sequencing Could Change With Complementary Combinations and CAR T Options in B-ALL - OncLive - November 8th, 2021
- Parkinson's gene therapy restores responses to dopamine-boosting drug in mouse models - FierceBiotech - November 8th, 2021
- Studies: CAR-T therapies superior to standard treatment in blood cancer - STAT - November 8th, 2021
- Salit Discusses the Use of Staging and Grading for Patients With GVHD to Choose Appropriate Treatment - Targeted Oncology - November 8th, 2021
- Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Updates - BioSpace - November 8th, 2021
- Global Stem Cell Therapy Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2026 - Northwest Diamond Notes - November 8th, 2021
- BioLineRx Announces an Oral Presentation and Three Poster Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting &... - November 8th, 2021
- CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results - Yahoo Finance - November 8th, 2021
- Bacterial Infections Linked with Unapproved Stem Cell Treatments - Contagionlive.com - October 28th, 2021
- Team finds way to enhance stem cell therapy for CNS injuries - BioPharma-Reporter.com - October 28th, 2021
- Stem cell therapy can help combat common symptoms of aging - The Mountaineer - October 28th, 2021
- Stem Cells Used to Treat Avascular Necrosis of the Femoral Head - Yale School of Medicine - October 28th, 2021
- Vitti Labs Announces FDA Approval of IND Application for Phase II Clinical Trial of Combination Mesenchymal Stem Cell and Exosome Treatment of Novel... - October 28th, 2021
- Biohaven Enrolls Phase 1a/1b Clinical Trial of BHV-1100, Lead Asset from its ARM (Antibody Recruiting Molecule) Platform, in Combination with NK Cell... - October 28th, 2021
- The Power of the Immune System: New Treatment for Painful Blood Cancer Side Effect - Curetoday.com - October 28th, 2021
- Global Cell Therapy Market Research Report 2021: Opportunities with the Approval of Kymriah and Yescarta Across Various Countries -... - October 28th, 2021
- Pursuing Optimal Therapy Remains a Challenge in Indolent B-Cell Lymphoma - Targeted Oncology - October 28th, 2021
- Stem Cell Therapy Market Research Report by Cell Source, by Type, by Therapeutic Application, by End-User, by Region - Global Forecast to 2026 -... - October 16th, 2021
- Harvard's R&D alliance with Resilience to advance manufacture of complex medicines - Harvard Gazette - October 16th, 2021
- A New Line of Defense in Blood Cancer: Natural Killer Cell Therapy - Curetoday.com - October 16th, 2021
- Dr. Kahl on the Potential Utility of Frontline CAR T-Cell Therapy in MCL - OncLive - October 16th, 2021
- Rheumatoid Arthritis Stem Cell Therapy Market By Type (Allogeneic Mesenchymal Stem Cells, Bone Marrow Transplant, Adipose Tissue Stem Cells) and By... - October 16th, 2021
- Orchard Therapeutics Outlines Comprehensive Presence at the European Society of Gene & Cell Therapy Congress - Yahoo Finance - October 16th, 2021
- Taking aim at the brain, Takeda strikes up cell therapy R&D alliance with Immusoft - MedCity News - October 16th, 2021
- Dr. Erba on the Evolution of Treatment in MCL - OncLive - October 16th, 2021
- Newer Agents for DLBCL Show Potential for Earlier Use in the Course of Treatment - Targeted Oncology - October 16th, 2021
- FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With Early Non-Small Cell Lung Cancer - Business Wire - October 16th, 2021
- Worldwide Cell Therapy Consumables Industry to 2031 - Featuring Bio-Techne, Irvine Scientific and Sartorius Among Others - PRNewswire - October 16th, 2021
- International ZIM Network: SmartMed - Regenerative Solutions for the Therapies of Tomorrow - Business Wire - October 16th, 2021
- BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization -... - October 16th, 2021
- FTC Follows Through On Prioritizing Investigations Into False Advertising In Healthcare Markets - Media, Telecoms, IT, Entertainment - United States -... - October 16th, 2021
- Molecular Atlas of Small Cell Lung Cancer Reveals Unusual Cell Type That Could Explain Why Its So Aggressive - On Cancer - Memorial Sloan Kettering - October 16th, 2021
- Actress Jennifer Garner Visits with 7-Year-Old Girl Fighting B-cell Acute Lymphoblastic Leukemia; What is the Treatment for This Disease? -... - October 16th, 2021
- Four-year-old girl with stage four cancer trying to get to America for clinical trial - Lancashire Telegraph - October 16th, 2021
- Stem cell & gene therapy to treat osteogenesis imperfecta: hype or hope - Open Access Government - October 5th, 2021
- Chennai-based institute to begin clinical trial on stem cell therapy for liver disease - The New Indian Express - October 5th, 2021
- "Stem cell-based therapeutics poised to become mainstream option - BSA bureau - October 5th, 2021
- Anja Health Disrupts Cord Blood Banking with Heartfelt Founding Story and Ground-Breaking Mission - Digital Journal - October 5th, 2021
- Longeveron Successfully Advancing its Cell-Based Therapy Studies in a Growing Industry Segment - Yahoo Finance - October 5th, 2021
- Ready to Treat Over 80 Life-Threatening Diseases, Discover the Potential of Cord Blood during World Cord Blood Day 2021 - PRNewswire - October 5th, 2021
- Transforming Growth Factor Sales Gaining Traction & to reach US$ 709.9 Mn with Significant Development in Cell Therapy Research - PRNewswire - October 5th, 2021
- StemExpress Partners with the Alliance for Regenerative Medicine to Provide COVID-19 Testing for the Cell and Gene Meeting on the Mesa - WITN - October 5th, 2021
- Brazil investigates the use of stem cells in the treatment of covid-19 The Clare People - The Clare People - October 5th, 2021
- Indianapolis mother gives 13-year-old son with sickle cell disease a 2nd chance at life - WTHR - October 5th, 2021
- US FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia | DNA RNA and... - October 5th, 2021
- Lack of awareness about blood stem cell donation is one of the leading causes for low number of donors in In.. - ETHealthworld.com - October 5th, 2021
- The Best Skincare Treatments For Time-Crunched Moms (Or Anyone Else Who Only Has Five Minutes To Spare) - Forbes - October 5th, 2021
- [PDF] Stem Cell Therapy Market Size Strong Revenue and Generated Opportunities UNLV The Rebel Yell - UNLV The Rebel Yell - August 31st, 2021
- Mike Tysons weird stem cell treatment has helped transform incredible body at 55 - Daily Star - August 31st, 2021
- Acute Monocytic Leukemia: Causes, Symptoms, and Treatment - Healthline - August 31st, 2021
- UC Davis and the School of Medicine set new records in research funding - UC Davis Health - August 31st, 2021
- NCCN Issues Updated Guidelines Regarding Third COVID-19 Vaccine Booster for Those With Cancer - Cancer Network - August 31st, 2021
- DHEC Supports Awareness and Education during National Sickle Cell Awareness Month - SCDHEC - August 31st, 2021
- The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation - DocWire News - August 31st, 2021
- Global Cryopreservation Equipment Market Report 2021-2028 - Growing Acceptance for Regenerative Medicine & Increasing Needs of Biobanking... - August 31st, 2021
- Operational Highlights and Financial Results for the Year Ended June 30, 2021 - GlobeNewswire - August 31st, 2021
- Event to benefit 2 families with kids fighting cancer - Youngstown Vindicator - August 31st, 2021
- Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market - GlobeNewswire - August 31st, 2021
- Incyte and MorphoSys Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults... - August 31st, 2021
- Thomas Smeenk with an update on the FDA Phase II clinical trial program of the Hemostemix blood-derived, stem cell therapeutics product (ACP-01) -... - August 31st, 2021
- 2021 Pipeline Insight Report on Myocardial Infarction - Featuring AstraZeneca, Mesoblast and Boehringer Ingelheim Among Others -... - August 31st, 2021
- Mini brains grown in the lab sprout primitive eyes - Freethink - August 31st, 2021
- BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA (Dinutuximab Beta) for Patients With High-Risk Neuroblastoma - Business Wire - August 18th, 2021